Autopsy report · NCT04861428

Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)

“Investigator left institution and did not retain the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 10 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Pittsburgh

Sponsor type

University, hospital or other

Conditions

Smoking Behaviors

Interventions

IQOS; Smoking as Usual

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (87% match in meaning)
• Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections
  “Investigator Left Institution” (86% match in meaning)
• Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
  “Principle investigator left the institution” (83% match in meaning)
• Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger
  “Due to the investigator leaving the institution, the study was terminated” (83% match in meaning)
• TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory
  “The study principle investigator left the institution.” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.